$LFVN
Lifevantage Corp

2024 Q2 Form 10-Q Financial Statement

#000084914624000047 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $48.93M $48.25M
YoY Change -9.76% -10.23%
Cost Of Revenue $10.02M $10.17M
YoY Change -9.46% -4.2%
Gross Profit $38.91M $38.07M
YoY Change -9.83% -11.71%
Gross Profit Margin 79.52% 78.92%
Selling, General & Admin $36.00M $16.43M
YoY Change -11.22% -7.25%
% of Gross Profit 92.52% 43.14%
Research & Development $200.0K
YoY Change 0.0%
% of Gross Profit 0.53%
Depreciation & Amortization $806.0K $895.0K
YoY Change -10.54% 2.99%
% of Gross Profit 2.07% 2.35%
Operating Expenses $36.00M $36.14M
YoY Change -11.22% -12.97%
Operating Profit $2.910M $1.934M
YoY Change 11.79% 20.95%
Interest Expense -$151.0K -$24.00K
YoY Change 128.79% -100.07%
% of Operating Profit -5.19% -1.24%
Other Income/Expense, Net -$48.00K -$13.00K
YoY Change -352.63% -119.7%
Pretax Income $2.711M $1.921M
YoY Change 6.06% 15.38%
Income Tax $1.406M $262.0K
% Of Pretax Income 51.86% 13.64%
Net Earnings $1.305M $1.659M
YoY Change -33.62% 62.33%
Net Earnings / Revenue 2.67% 3.44%
Basic Earnings Per Share $0.13
Diluted Earnings Per Share $0.10 $0.13
COMMON SHARES
Basic Shares Outstanding 12.70M shares 12.87M shares
Diluted Shares Outstanding 12.99M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.89M $17.38M
YoY Change -21.84% -11.02%
Cash & Equivalents $16.89M $17.38M
Short-Term Investments
Other Short-Term Assets $2.443M $2.763M
YoY Change -48.6% -17.42%
Inventory $15.06M $15.16M
Prepaid Expenses
Receivables $2.949M $2.135M
Other Receivables $313.0K $360.0K
Total Short-Term Assets $37.65M $37.80M
YoY Change -14.99% -14.76%
LONG-TERM ASSETS
Property, Plant & Equipment $7.813M $8.349M
YoY Change -14.01% -11.69%
Goodwill
YoY Change
Intangibles $323.0K $356.0K
YoY Change -29.01% -27.05%
Long-Term Investments
YoY Change
Other Assets $680.0K $496.0K
YoY Change 19.51% -62.05%
Total Long-Term Assets $22.65M $23.51M
YoY Change 3.73% 3.39%
TOTAL ASSETS
Total Short-Term Assets $37.65M $37.80M
Total Long-Term Assets $22.65M $23.51M
Total Assets $60.30M $61.31M
YoY Change -8.81% -8.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.853M $6.954M
YoY Change 66.99% 19.42%
Accrued Expenses $7.874M $14.75M
YoY Change -0.73% -5.33%
Deferred Revenue $860.0K $700.0K
YoY Change 3.12%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.31M $22.48M
YoY Change 13.77% 5.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $198.0K $211.0K
YoY Change -33.78% -33.86%
Total Long-Term Liabilities $198.0K $211.0K
YoY Change -33.78% -33.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.31M $22.48M
Total Long-Term Liabilities $198.0K $211.0K
Total Liabilities $34.31M $34.54M
YoY Change 9.0% 2.67%
SHAREHOLDERS EQUITY
Retained Earnings -$108.7M -$107.7M
YoY Change 10.61% 8.79%
Common Stock $136.6M $136.2M
YoY Change 1.73% 2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.99M $26.77M
YoY Change
Total Liabilities & Shareholders Equity $60.30M $61.31M
YoY Change -8.81% -8.61%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.305M $1.659M
YoY Change -33.62% 62.33%
Depreciation, Depletion And Amortization $806.0K $895.0K
YoY Change -10.54% 2.99%
Cash From Operating Activities $2.582M $3.093M
YoY Change -31.38% -10.17%
INVESTING ACTIVITIES
Capital Expenditures $278.0K $291.0K
YoY Change -45.81% -70.61%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$278.0K -$291.0K
YoY Change -44.95% -70.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.741M -2.464M
YoY Change 107.18% 705.23%
NET CHANGE
Cash From Operating Activities 2.582M 3.093M
Cash From Investing Activities -278.0K -291.0K
Cash From Financing Activities -2.741M -2.464M
Net Change In Cash -437.0K 338.0K
YoY Change -122.58% -84.26%
FREE CASH FLOW
Cash From Operating Activities $2.582M $3.093M
Capital Expenditures $278.0K $291.0K
Free Cash Flow $2.304M $2.802M
YoY Change -29.11% 14.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12622000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12622000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151233000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159177000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10172000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10618000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31418000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32318000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
38073000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
43123000 usd
us-gaap Gross Profit
GrossProfit
119815000 usd
us-gaap Gross Profit
GrossProfit
126859000 usd
CY2024Q1 lfvn Commission And Incentives
CommissionAndIncentives
19714000 usd
CY2023Q1 lfvn Commission And Incentives
CommissionAndIncentives
23816000 usd
lfvn Commission And Incentives
CommissionAndIncentives
63941000 usd
lfvn Commission And Incentives
CommissionAndIncentives
71185000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16425000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54452000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54018000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
36139000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
41524000 usd
us-gaap Operating Expenses
OperatingExpenses
118393000 usd
us-gaap Operating Expenses
OperatingExpenses
125203000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1934000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-135000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-304000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
66000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
217000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-213000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1921000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1665000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1639000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1443000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
262000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
643000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
869000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1659000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1022000 usd
us-gaap Net Income Loss
NetIncomeLoss
1632000 usd
us-gaap Net Income Loss
NetIncomeLoss
574000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12424000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12615000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12525000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12538000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12986000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12770000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13010000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12555000 shares
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-529000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-360000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
144000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-529000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-360000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
144000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1130000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1036000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1272000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
718000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
34649000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
978000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
465000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
795000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
126000 usd
CY2023Q3 us-gaap Dividends Cash
DividendsCash
5534000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-294000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
29294000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
750000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
213000 usd
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1876000 usd
CY2023Q4 us-gaap Dividends Cash
DividendsCash
455000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
463000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-656000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
27307000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12688000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12688000 shares
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17708000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1599000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1422000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
76000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
59000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
352000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
91000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
14000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
796000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
145000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
233000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1928000 usd
CY2024Q1 us-gaap Dividends Cash
DividendsCash
448000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-529000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1659000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
26769000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
31516000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
602000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
72000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
121000 usd
CY2022Q3 us-gaap Dividends Cash
DividendsCash
377000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-510000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
610000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31890000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
823000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19000 usd
CY2022Q4 us-gaap Dividends Cash
DividendsCash
381000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
640000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1058000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31895000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
817000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
131000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
54000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
383000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
33442000 usd
us-gaap Net Income Loss
NetIncomeLoss
1632000 usd
us-gaap Net Income Loss
NetIncomeLoss
574000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2775000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2678000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2524000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2242000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
920000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1257000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-24000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1936000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-953000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
552000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-975000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
118000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1090000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-725000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1947000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1983000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1859000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-59000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-55000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3385000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1642000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
772000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-453000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1549000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1301000 usd
lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1120000 usd
lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1274000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
115000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-119000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9615000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3065000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1967000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2554000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1967000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2554000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4599000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
6437000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1141000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
911000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
145000 usd
lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
271000 usd
lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
252000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11676000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1034000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-200000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-138000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4228000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-661000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21605000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20190000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17377000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19529000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
us-gaap Interest Paid Net
InterestPaidNet
3000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1381000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
977000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America ("GAAP"). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div>
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
36000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-200000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-200000 usd
CY2024Q1 lfvn Handling And Restocking Fee Percentage
HandlingAndRestockingFeePercentage
0.10
CY2024Q1 lfvn Return Liability Reserve
ReturnLiabilityReserve
100000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </span>such risk. Financial instruments with significant credit risk include cash and investments.
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11273000 usd
CY2024Q1 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.744
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12153000 usd
CY2023Q2 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.756
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3889000 usd
CY2024Q1 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.256
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3920000 usd
CY2023Q2 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.244
CY2024Q1 us-gaap Inventory Net
InventoryNet
15162000 usd
CY2024Q1 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2023Q2 us-gaap Inventory Net
InventoryNet
16073000 usd
CY2023Q2 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1300000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1300000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
700000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
800000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-200000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 usd
lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
lfvn Contracts With Customers Return Period For Resalable And Restockable Items
ContractsWithCustomersReturnPeriodForResalableAndRestockableItems
P12M
CY2024Q1 lfvn Contracts With Customers Refund Percent For Resalable And Restockable Items
ContractsWithCustomersRefundPercentForResalableAndRestockableItems
1
CY2023Q2 lfvn Return Liability Reserve
ReturnLiabilityReserve
100000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
500000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
400000 usd
CY2023Q1 us-gaap Loss On Contract Termination
LossOnContractTermination
400000 usd
us-gaap Loss On Contract Termination
LossOnContractTermination
400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1659000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1022000 usd
us-gaap Net Income Loss
NetIncomeLoss
1632000 usd
us-gaap Net Income Loss
NetIncomeLoss
574000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12424000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12615000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12525000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12538000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
562000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
155000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
485000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12986000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12770000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13010000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12555000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
us-gaap Operating Lease Cost
OperatingLeaseCost
1929000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
42000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
20
CY2023Q3 lfvn Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable
ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable
0.12
CY2023Q3 lfvn Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable Passive Investors
ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors
0.20
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
103000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
136000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
189000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
12000 usd
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48245000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53741000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
151233000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159177000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M10D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0326
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M7D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0325
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
600000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1600000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2200000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
459000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
516000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1451000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
35000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
63000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
513000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
637000 usd
us-gaap Lease Cost
LeaseCost
1622000 usd
us-gaap Lease Cost
LeaseCost
2181000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
560000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
782000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1651000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2288000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
265000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1767000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
550000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2025000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2068000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2080000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2057000 usd
CY2024Q1 lfvn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
6394000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15174000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1647000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
13527000 usd
CY2023Q3 lfvn Debt Instrument Covenant Maximum Dividend
DebtInstrumentCovenantMaximumDividend
750000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
200000 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
36000 shares
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 usd
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
700000 shares
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1900000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4600000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
22300000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q3 lfvn Class Of Warrants Or Right Discount
ClassOfWarrantsOrRightDiscount
0.50
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
400000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6400000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.035
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.51
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
400000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1100000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.03
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.09
CY2024Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
25000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
40000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
64000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
76000 shares
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
800000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
800000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2500000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2200000 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of March 31, 2024, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000849146-24-000047-index-headers.html Edgar Link pending
0000849146-24-000047-index.html Edgar Link pending
0000849146-24-000047.txt Edgar Link pending
0000849146-24-000047-xbrl.zip Edgar Link pending
evolvecompensationplanca.htm Edgar Link pending
evolvecompensationplanca001.jpg Edgar Link pending
evolvecompensationplanca002.jpg Edgar Link pending
evolvecompensationplanca003.jpg Edgar Link pending
evolvecompensationplanca004.jpg Edgar Link pending
evolvecompensationplanca005.jpg Edgar Link pending
evolvecompensationplanca006.jpg Edgar Link pending
evolvecompensationplanca007.jpg Edgar Link pending
evolvecompensationplanca008.jpg Edgar Link pending
evolvecompensationplanca009.jpg Edgar Link pending
evolvecompensationplanca010.jpg Edgar Link pending
evolvecompensationplanca011.jpg Edgar Link pending
evolvecompensationplanca012.jpg Edgar Link pending
evolvecompensationplanca013.jpg Edgar Link pending
evolvecompensationplaneu.htm Edgar Link pending
evolvecompensationplaneu001.jpg Edgar Link pending
evolvecompensationplaneu002.jpg Edgar Link pending
evolvecompensationplaneu003.jpg Edgar Link pending
evolvecompensationplaneu004.jpg Edgar Link pending
evolvecompensationplaneu005.jpg Edgar Link pending
evolvecompensationplaneu006.jpg Edgar Link pending
evolvecompensationplaneu007.jpg Edgar Link pending
evolvecompensationplaneu008.jpg Edgar Link pending
evolvecompensationplaneu009.jpg Edgar Link pending
evolvecompensationplaneu010.jpg Edgar Link pending
evolvecompensationplaneu011.jpg Edgar Link pending
evolvecompensationplaneu012.jpg Edgar Link pending
evolvecompensationplaneu013.jpg Edgar Link pending
evolvecompensationplanme.htm Edgar Link pending
evolvecompensationplanme001.jpg Edgar Link pending
evolvecompensationplanme002.jpg Edgar Link pending
evolvecompensationplanme003.jpg Edgar Link pending
evolvecompensationplanme004.jpg Edgar Link pending
evolvecompensationplanme005.jpg Edgar Link pending
evolvecompensationplanme006.jpg Edgar Link pending
evolvecompensationplanme007.jpg Edgar Link pending
evolvecompensationplanme008.jpg Edgar Link pending
evolvecompensationplanme009.jpg Edgar Link pending
evolvecompensationplanme010.jpg Edgar Link pending
evolvecompensationplanme011.jpg Edgar Link pending
evolvecompensationplanme012.jpg Edgar Link pending
evolvecompensationplanme013.jpg Edgar Link pending
evolvecompensationplanuk.htm Edgar Link pending
evolvecompensationplanuk001.jpg Edgar Link pending
evolvecompensationplanuk002.jpg Edgar Link pending
evolvecompensationplanuk003.jpg Edgar Link pending
evolvecompensationplanuk004.jpg Edgar Link pending
evolvecompensationplanuk005.jpg Edgar Link pending
evolvecompensationplanuk006.jpg Edgar Link pending
evolvecompensationplanuk007.jpg Edgar Link pending
evolvecompensationplanuk008.jpg Edgar Link pending
evolvecompensationplanuk009.jpg Edgar Link pending
evolvecompensationplanuk010.jpg Edgar Link pending
evolvecompensationplanuk011.jpg Edgar Link pending
evolvecompensationplanuk012.jpg Edgar Link pending
evolvecompensationplanuk013.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfvn-20240331.htm Edgar Link pending
lfvn-20240331.xsd Edgar Link pending
lfvn_33124xex311.htm Edgar Link pending
lfvn_33124xex312.htm Edgar Link pending
lfvn_33124xex321.htm Edgar Link pending
lfvn_33124xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
lfvn-20240331_cal.xml Edgar Link unprocessable
lfvn-20240331_def.xml Edgar Link unprocessable
lfvn-20240331_lab.xml Edgar Link unprocessable
lfvn-20240331_pre.xml Edgar Link unprocessable
lfvn-20240331_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable